首页> 美国卫生研究院文献>Neurologia medico-chirurgica >Endovascular Therapy for Intracranial Artery Stenosis: Results from the Japanese Registry of Neuroendovascular Therapy (JR-NET)3
【2h】

Endovascular Therapy for Intracranial Artery Stenosis: Results from the Japanese Registry of Neuroendovascular Therapy (JR-NET)3

机译:颅内动脉狭窄的血管内治疗:日本神经内血管治疗注册中心(JR-NET)3的结果

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

A total of 907 patients enrolled in the Japanese Registry of Neuroendovascular Therapy (JR-NET)3, a surveillance study in Japan, who underwent intracranial percutaneous transluminal angioplasty (PTA)/stenting for intracranial stenosis during the period from 2010 to 2014 were investigated. Technical success was achieved in 97.5% of the patients, and 6.8% had a residual stenosis of ≥50%. The incidence rates of ischemic and hemorrhagic complications were as low as 5.3% and 3.1%, respectively, and the mortality rate was 1.9%. However, the mortality rate of cases with either complications was higher at 10.7%. About half of the treatment cases were performed between 24 h and 14 days after onset, and the incidence of perioperative complications was similar to that after at least 15 days. Although it is necessary to verify the effectiveness of PTA/stenting within 14 days, the results of this treatment were stable regardless of the intervention period.
机译:在2010年至2014年期间,对在日本进行的一项监测研究-日本神经内膜血管治疗注册(JR-NET)3登记的总共907例患者进行了颅内经皮腔内血管成形术(PTA)/支架置入术。 97.5%的患者取得了技术成功,而6.8%的残余狭窄≥50%。缺血性和出血性并发症的发生率分别低至5.3%和3.1%,死亡率为1.9%。然而,任一并发症的死亡率均较高,为10.7%。约有一半的治疗病例在发病后24小时至14天之间进行,围手术期并发症的发生率与至少15天后相似。尽管有必要在14天内验证PTA /支架的有效性,但无论干预时间长短,该治疗的结果都是稳定的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号